RT Book, Section A1 Ciccone, Charles D. SR Print(0) ID 1180857393 T1 Treatment of Infections III: Antifungal and Antiparasitic Drugs T2 Pharmacology in Rehabilitation YR 2016 FD 2016 PB F. A. Davis Company PP New York, NY SN 9780803640290 LK fadavispt.mhmedical.com/content.aspx?aid=1180857393 RD 2024/03/28 AB Humans are susceptible to infection by a number of parasitic species of fungi, protozoa, and helminths (worms). Although some types of parasitic infections are limited or unknown in developed nations such as the United States, parasitic infections generally represent the most common form of disease worldwide. These infections are especially prevalent in tropical and subtropical environments and in impoverished areas of the world where sanitation and hygiene are inadequate. In addition, the incidence of serious fungal and other parasitic infections has been increasing in industrialized nations because of the increased susceptibility of immunocompromised patients to these infections, such as patients with AIDS or those receiving immunosuppressant drugs after organ transplantation.1–3 Hence, the effective pharmacological treatment of these infections remains an important topic in the global management of disease.